This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This piece highlights which crypto has the smallest price swings and what that means for portfolio balance, risk management, and returns.
28,114 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Costco’s price action has moved back toward the $1,000 level, prompting a careful look at whether the stock deserves ...
Netflix stock flirting with a pivotal price level has investors weighing a potential decade-long opportunity against ...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
Nvidia stock investors just received a wave of bullish commentary from analysts as AI demand powers data centers and ...
When a new Berkshire CEO speaks candidly about returns, investors sit up. This article digs into what 'greg abel call...
In 2026, memory-chip names Micron and Sandisk have surged past Nvidia, reshaping the AI stock landscape. This article...
Verizon sits near a 52-week high while AT&T hovers around a key level near $23, prompting renewed investor scrutiny o...
A new Harvard study shows the income needed to afford median-priced homes has nearly doubled since 2020, highlighting...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A sharp dip can set off alarm bells, but it can also open doors. This article digs into why Qualcomm stock down 28% h...